Gkv Capital Management Co., Inc. Novavax Inc Transaction History
Gkv Capital Management Co., Inc.
- $120 Billion
- Q1 2025
A detailed history of Gkv Capital Management Co., Inc. transactions in Novavax Inc stock. As of the latest transaction made, Gkv Capital Management Co., Inc. holds 120 shares of NVAX stock, worth $870. This represents 0.0% of its overall portfolio holdings.
Number of Shares
120Holding current value
$870% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding NVAX
# of Institutions
299Shares Held
90.4MCall Options Held
5.76MPut Options Held
6.65M-
Vanguard Group Inc Valley Forge, PA15.7MShares$114 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.8MShares$85.9 Million0.0% of portfolio
-
Shah Capital Management11.1MShares$80.7 Million33.15% of portfolio
-
State Street Corp Boston, MA7.04MShares$51 Million0.0% of portfolio
-
Coatue Management LLC New York, NY3.84MShares$27.8 Million0.13% of portfolio
About NOVAVAX INC
- Ticker NVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,215,104
- Market Cap $567M
- Description
- Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...